首页> 外文OA文献 >An international dosimetry exchange for boron neutron capture therapy, Part I: Absorbed dose measurements
【2h】

An international dosimetry exchange for boron neutron capture therapy, Part I: Absorbed dose measurements

机译:硼中子俘获治疗的国际剂量学交流,第一部分:吸收剂量测量

摘要

An international collaboration was organized to undertake a dosimetry exchange to enable the future combination of clinical data from different centers conducting neutron capture therapy trials.As a first step Part I the dosimetry group from the Americas, represented by MIT, visited the clinical centers at Studsvik Sweden, VTT Espoo Finland, and the Nuclear Research Institute NRI at Rez Czech Republic. A combined VTT/NRI group reciprocated with a visit to MIT. Each participant performed a series of dosimetry measurements under equivalent irradiation conditions using methods appropriate to their clinical protocols. This entailed in-air measurements and dose versus depth measurements in a large water phantom. Thermal neutron flux as well as fast neutron and photon absorbed dose rates were measured. Satisfactory agreement in determining absorbed dose within the experimental uncertainties was obtained between the different groups although the measurement uncertainties are large, ranging between 3% and 30% depending upon the dose component and the depth of measurement. To improve the precision in the specification of absorbed dose amongst the participants, the individually measured dose components were normalized to the results from a single method. Assuming a boron concentration of 15 microg/g that is typical of concentrations realized clinically with the boron delivery compound boronophenylalanine-fructose, systematic discrepancies in the specification of the total biologically weighted dose of up to 10% were apparent between the different groups. The results from these measurements will be used in future to normalize treatment plan calculations between the different clinical dosimetry protocols as Part II of this study.
机译:组织了一次国际合作以进行剂量学交换,以使未来进行中子俘获疗法试验的不同中心的临床数据得以合并。第一步,以麻省理工学院为代表的美洲剂量学小组访问了Studsvik的临床中心瑞典,芬兰的VTT Espoo和位于捷克共和国Rez的NRI核研究所。 VTT / NRI联合小组对麻省理工学院进行了访问。每个参与者使用适合其临床方案的方法,在等效辐射条件下进行一系列剂量测定。这需要在大型水体模型中进行空中测量以及剂量与深度的对比。测量了热中子通量以及快速中子和光子吸收剂量率。尽管测量不确定度很大,根据剂量成分和测量深度的不同,测量不确定度很大,但在不同的试验组之间,在确定吸收剂量方面仍取得了令人满意的一致性。为了提高参与者之间吸收剂量规格的精度,将单独测量的剂量成分标准化为单一方法的结果。假定硼浓度为15微克/克,这是硼递送化合物硼苯丙氨酸-果糖在临床上所实现的典型浓度,则不同组之间的总生物加权剂量规格中的系统差异会明显达到10%。这些测量的结果将在将来用于标准化不同临床剂量测定规程之间的治疗计划计算,作为本研究的第二部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号